- ECONOMIC IMPACT -

Economists and institutions have cut their forecasts and experts are predicting the potential onset of recessionary environments.

Global companies are also concerned about the rising risk of Covid-19, with thousands of the world’s leading companies explicitly mentioning its impact on their business in their latest company filings.

-4.7%

The IMF estimates growth of -4.7% for the Middle East and Central Asian region.

9.5%

Goldman Sachs expects UK unemployment to rise to 9.5% by December 2020 because its job retention scheme ends in October.

Maximum, Minimum and Mean of all new GDP growth estimates by week​​​​​​​

- SECTOR IMPACT: MEDICAL -

As of 29 July 2020

CardiovASCULAR Devices

Among the cardiovascular markets, pacemakers have been particularly hit by the pandemic. GlobalData estimates the US market for pacemaker devices was worth $782m in 2019, but as a result of Covid-19, the 2020 market value has been cut by around 50% of previous estimates for 2020, to $400m, with the market not recovering to a status resembling pre-Covid-19 until 2022.

15.7%

The Spinal Fusion market is expected to contract by 15.7% in 2020, and slowly recover during 2021.

General Surgery Devices

29

In the US,  more than 29 states have allowed the resumption of general surgeries but under strict guidelines to prevent further Covid-19 infection. 

Key mediCal market developments

Share this article

Go to article: Home | The triumph of telemedicineGo to article: In This IssueGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: ContentsGo to article: ElectroCraft Company InsightGo to article: ElectroCraftGo to article: NewsGo to article: Coronavirus Executive BriefingGo to article: Helbling Go to article: Phosphorus and BioIQ announce partnership for at-home Covid-19 testing kitsGo to article: Roche’s Covid-19 tests could be enough to offset losses during lockdownGo to article: CRISPR biotechnology set to disrupt Covid-19 testing marketGo to article: Resumption of elective surgeries in the US to be short-livedGo to article: Abbott’s ID NOW Covid-19 test under questionGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: The medical industry briefingGo to article: Mus musculus: how nanofluidic drug delivery could counter muscle loss in spaceGo to article: Coding in medtech: setting standards for the digital ageGo to article: SartoriusGo to article: Will digital mental health solutions thrive after Covid-19?Go to article: South Korea: the rise of a new medtech giant? Go to article: ICF MercantileGo to article: Is there a bright future for telemedicine in a post-Covid world?Go to article: PSN LabsGo to article: Q&A: discussing cancer blood testing tech with VolitionGo to article: dokspotGo to article: What does the MDR delay mean for the European medtech sector?Go to article: Covid-19 immunity passports: how to protect health dataGo to article: The key list powered by GlobalDataGo to article: Deals in brief powered by GlobalDataGo to article: TS Quality & EngineeringGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2 ) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next Issue